3409 results for «2023»
3409 results
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
What is the role of intra-coronary physiology and imaging to guide left main bifurcation PCI?
17 May 2023 – From EuroPCR 2023
As Alejandro Travieso explains, physiology and imaging are complementary to achieve good assessment of left main PCI. Dejan Milasinovic adds that different imaging tools can be used in different patients, so practitioners may choose between OCT and IVUS, depending on their main target of interest.
Find out the specifics...
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
Treating a wide range of patient anatomies with the PASCAL implants
06 Dec 2023 – From PCR London Valves 2023
Sam Dawkins, Niklas Schofer and Mirjam Wild share the latest experience on Pascal implants for mitral and tricuspid TEER. Together they discuss the rationale for using the same device for mitral and tricuspid, how the skills and knowledge on MR can be used for TR,...
The revolution coming to tricuspid valve treatment with the EVOQUE replacement system
06 Dec 2023 – From PCR London Valves 2023
Marianna Adamo and Philipp Lurz summarize the results of the TRISCEND II randomized trial which addresses the question of transcatheter tricuspid replacement (using the EVOQUE system) vs OMT. Find out more about the key findings at 6 months and the relevance for your practice
This interview was...
Recent clinical evidence for mitral TEER the CLASP IID trial
06 Dec 2023 – From PCR London Valves 2023
What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.
This...
Pregnant women working in the cathlab
17 May 2023 – From EuroPCR 2023
Lynn Hinterbuchner welcomes Angeliki Kolyda, radiographer, in the PCR TV studio, in the heart of EuroPCR 2023, to talk about pregnancy in the cathlab. Should a woman really worry about working in a cathlab? If so, why? When exactly? How can she best protect herself?
Follow this...
When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?
17 May 2023 – From EuroPCR 2023
What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?
These are the questions Vijay Kunadian and Martine Gilard...
What is the best contemporary interventional management of out-of-hospital cardiac arrest?
17 May 2023 – From EuroPCR 2023
Thomas Keeble and Marko Noc tackle the tricky question of how to deal with a patient with out-of-hospital cardiac arrest.
While STEMI patients should almost invariably go directly to the cathlab, the situation seems less clear-cut for non-ST-elevation patients, for whom a genuinely personalized approach needs to be proposed.
Study...
When to use drug coated balloons in de novo lesions?
What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.
Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...
How to prepare an excellent abstract for EuroPCR?
17 May 2023 – From EuroPCR 2023
Marjo De Ronde asks Davide Capodanno, Chief Editor of the EuroIntervention Journal, to describe the main steps for nurses, allied health professionals and researchers to get started with research.
If motivation and passion are the key words, the starting point remains the idea, which must be relevant, and...
Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation
17 May 2023 – From EuroPCR 2023
Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.
To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.
The content...
Should we perform revascularisation in patients with depressed left ventricle ejection fraction?
17 May 2023 – From EuroPCR 2023
Divaka Perera, main author of the REVIVED study, discusses the results of this trial with Flavio Ribichini.
REVIVE was a trial of severe ischaemic cardiomyopathy in which the primary outcome was death or heart failure hospitalization.The headline result was that there was absolutely no difference with PCI,...
